Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Cortez AJ, Tudrej P, Kujawa KA, et al. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol. 2018;81:17–38.
   PubMed Web of Science ®Google Scholar
• Casagrande JT, Louie EW, Pike MC, et al. “Incessant ovulation” and ovarian cancer. Lancet. 1979;2:170–173.
   PubMed Web of Science ®Google Scholar
• Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 1983;71:717–721.
   PubMedGoogle Scholar
• Pandey R, Woo HH, Varghese F, et al. Circulating miRNA profiling of women at high risk for ovarian cancer. Transl Oncol. 2019;12:714–725.
   PubMed Web of Science ®Google Scholar
• Marton E, Lukacs J, Penyige A, et al. Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer. J Biotechnol. 2019;297:58–65.
   PubMed Web of Science ®Google Scholar
• Karedath T, Ahmed I, Al Ameri W, et al. Silencing of ANKRD12 circRNA induces molecular and functional changes associated with invasive phenotypes. BMC Cancer. 2019;19:565–581.
   PubMed Web of Science ®Google Scholar
• Bao L, Zhong J, Pang L. Upregulation of circular RNA VPS13C-hsa-circ-001567 promotes ovarian cancer cell proliferation and invasion. Cancer Biother Radiopharm. 2019;34:110–118.
   PubMed Web of Science ®Google Scholar
• Du WW, Zhang C, Yang W, et al. Identifying and characterizing circRNA-protein interaction. Theranostics. 2017;7:4183–4191.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Alexandrov PN, Jaber V, et al. Deficiency in the ubiquitin conjugating enzyme UBE2A in Alzheimer’s Disease (AD) is linked to deficits in a natural circular miRNA-7 sponge (circRNA; ciRS-7). Genes (Basel). 2016;7:116–124.
   PubMed Web of Science ®Google Scholar
• Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56:55–66.
   PubMed Web of Science ®Google Scholar
• Paramasivam N, Granzow M, Evers C, et al. Identification and prioritization of causal variants of human genetic disorders from exome or whole genome sequencing data. OBM Genet. 2018;2:017.
   Google Scholar
• Ping L, Jian-Jun C, Chu-Shu L, et al. Silencing of circ_0009910 inhibits acute myeloid leukemia cell growth through increasing miR-20a-5p. Blood Cells Mol Dis. 2019;75:41–47.
   PubMed Web of Science ®Google Scholar
• Liu M, Liu KD, Zhang L, et al. Circ_0009910 regulates growth and metastasis and is associated with poor prognosis in gastric cancer. Eur Rev Med Pharmacol Sci. 2018;22:8248–8256.
   PubMed Web of Science ®Google Scholar
• Deng N, Li L, Gao J, et al. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma. Biochem Biophys Res Commun. 2018;495:189–196.
   PubMed Web of Science ®Google Scholar
• Majem B, Parrilla A, Jimenez C, et al. MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways. Oncogene. 2019;38:6035–6050.
   PubMed Web of Science ®Google Scholar
• Salem M, Shan Y, Bernaudo S, et al. miR-590-3p targets cyclin G2 and FOXO3 to promote ovarian cancer cell proliferation, invasion, and spheroid formation. Int J Mol Sci. 2019;20:1810–1826.
   PubMed Web of Science ®Google Scholar
• Biamonte F, Santamaria G, Sacco A, et al. MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer. Sci Rep. 2019;9:5668.
   PubMed Web of Science ®Google Scholar
• Dori M, Bicciato S. Integration of bioinformatic predictions and experimental data to identify circRNA-miRNA associations. Genes (Basel). 2019;10:642–655.
   PubMed Web of Science ®Google Scholar
• Ahmed I, Karedath T, Andrews SS, et al. Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma. Oncotarget. 2016;7:36366–36381.
   PubMed Web of Science ®Google Scholar
• Caiment F, Gaj S, Claessen S, et al. High-throughput data integration of RNA-miRNA-circRNA reveals novel insights into mechanisms of benzo[a]pyrene-induced carcinogenicity. Nucleic Acids Res. 2015;43:2525–2534.
   PubMed Web of Science ®Google Scholar
• Song YZ, Li JF. Circular RNA hsa_circ_0001564 regulates osteosarcoma proliferation and apoptosis by acting miRNA sponge. Biochem Biophys Res Commun. 2018;495:2369–2375.
   PubMed Web of Science ®Google Scholar
• Li B, Xie F, Zheng FX, et al. Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer. J Huazhong Univ Sci Technolog Med Sci. 2017;37:886–890.
   PubMedGoogle Scholar
• Yuan Y, Liu W, Zhang Y, et al. CircRNA circ_0026344 as a prognostic biomarker suppresses colorectal cancer progression via microRNA-21 and microRNA-31. Biochem Biophys Res Commun. 2018;503:870–875.
   PubMed Web of Science ®Google Scholar
• Wu H, Xiao Z, Wang K, et al. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. Biochem Biophys Res Commun. 2013;441:693–700.
   PubMed Web of Science ®Google Scholar
• Kim TH, Song JY, Park H, et al. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma. Cancer Lett. 2015;356:937–945.
   PubMed Web of Science ®Google Scholar
• Dong R, Liu X, Zhang Q, et al. miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma. Oncotarget. 2014;5:10816–10829.
   PubMed Web of Science ®Google Scholar
• Zhu X, Li Y, Xie C, et al. miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. Int J Cancer. 2014;135:1286–1296.
   PubMed Web of Science ®Google Scholar
• Harrington BS, Annunziata CM. NF-kappaB signaling in ovarian cancer. Cancers (Basel). 2019;11:1182.
   PubMed Web of Science ®Google Scholar
• Momeny M, Yousefi H, Eyvani H, et al. Blockade of nuclear factor-kappaB (NF-kappaB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells. Int J Biochem Cell Biol. 2018;99:1–9.
   PubMed Web of Science ®Google Scholar
• Zhou J, Jain S, Azad AK, et al. Notch and TGFbeta form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells. Cell Signal. 2016;28:838–849.
   PubMed Web of Science ®Google Scholar
• Chiaramonte R, Colombo M, Bulfamante G, et al. Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1alpha chemokine system. Int J Biochem Cell Biol. 2015;66:134–140.
   PubMed Web of Science ®Google Scholar
• Colomiere M, Ward AC, Riley C, et al. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br J Cancer. 2009;100:134–144.
   PubMed Web of Science ®Google Scholar